Effects of Combined Treatment with Calcitriol plus Alendronate on Bone Mass and Bone Turnover in Postmenopausal Osteoporosis: Two Years of Continuous Treatment

Author： Frediani B.   Allegri A.   Bisogno S.   Marcolongo R.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.15, Iss.3, 1998-03, pp. : 235-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Treatment with Calcitriol Combined with Low-Dosage Alendronate in Involutional Osteoporosis

By Nuti R.   Martini G.   Giovani S.   Valenti R.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 55-61

Adis International

Access to resources Recommend Favorite

The Safety and Efficacy of Early-stage Bi-weekly Alendronate to Improve Bone Mineral Density and Bone Turnover in Chinese Post-menopausal Women at Risk of Osteoporosis

By You L   Sheng Z-Y   Chen J-Y   Pan L   Chen L  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 302-310

Field House Publishing

Access to resources Recommend Favorite

Biological Effects of Supplementation with Vitamin D and Calcium in Postmenopausal Women with Low Bone Mass Receiving Alendronate

By Brazier M.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 849-857

Adis International

Access to resources Recommend Favorite

Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of Osteoporosis

By  

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 451-459

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Statins on Bone Markers, Bone Mineral Density and Fractures. Possible Role in Osteoporosis Treatment

By  

Current Pharmaceutical Analysis, Vol. 2, Iss. 2, 2006-05 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite